Zimbabwe has turned down a substantial US healthcare agreement valued at 367 million US dollars (£272m) spanning five years due to Washington's request for sensitive biological samples.
This move came to light after a internal memorandum from December was leaked, revealing that Head of State Emmerson Mnangagwa believed the agreement was "skewed".
An official spokesman later explained that the United States was seeking biological samples for scientific study and profit while was unwilling to share the benefits from future medical innovations.
"We are forced to start the difficult and regrettable task of ending our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had furnished over $1.9bn for health programmes to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has appealed for further dialogue to reach a agreement agreeable to all parties so the nation's critical HIV treatment initiative can continue.
Wider Background
This development comes after a comparable situation in Kenya, where a court halted a related deal with the US following legal challenges were raised about the security of Kenyans' health data.
After returning to the presidency recently, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
The agency had overseen aid for the US government, but Trump claimed its expenditure was "inefficient" and his government was pursuing government-to-government deals to enhance transparency and accountability.
As per reports, Sixteen African countries have to date agreed to these new agreements, representing over $18.3bn in new funding.
Specifics of the Declined Deal
The money for Zimbabwe was intended to funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this collaboration might have yielded significant advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently on HIV treatment through US-supported initiatives," Tremont said.
However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".
"Our nation was requested to provide its genetic material and health information for a long time, with no corresponding assurance of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," he stated.
"In essence, our nation would provide the basic resources for medical research without any certainty that the resulting innovations would be available to our citizens if a new disease outbreak emerge."
Sovereignty and International Frameworks
He also noted that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were disrupting frameworks already established via the global health agency.
Mangwana cited its Pandemic Benefit-Sharing system created to deal with future global health emergencies.
"This system is designed to guarantee that when a country provides its samples, the benefits – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the capability to develop them."
Zimbabwe's reservations over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We encourage continued discussions with our US partners on how future co-operation might be arranged in a manner that honours the independence and interests of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but urged that negotiations need to persist given that much of the nation's Aids initiatives relied on foreign aid.
"Where specific concerns arise, including those relating to information security or agreement terms, these can frequently be resolved via technical clarification and mutually agreed protections," it commented.
This impasse highlights the complex challenges between accepting much-needed foreign assistance and safeguarding national sovereignty in an increasingly interconnected world.